ADHD:Systematic Review of Diagnosis and Treatment in Children and Adolescents

Psychologist

4.00 - CE credit hours training

$25.00 - Cost of course

This page contains important information about the course, including training details, a comprehensive course description, learning objectives, and source references. We encourage you to review each section to gain a clear understanding of the course content, educational goals, and supporting materials before beginning your training and taking the POST TEST below.

Target audience and instructional level of this course: foundational
There is no known conflict of interest or commercial support related to this CE program.

ADHD:Systematic Review of Diagnosis and Treatment in Children and Adolescents

Course Training

Follow the link below, read the material and then take the 24 question post test

Read the Course Material:
ADHD:Systematic Review of Diagnosis and Treatment in Children and Adolescents

Post Test

24 Questions

1. A key message of this Comparative Effectiveness Review comparing strategies to diagnose, treat and monitor children with attention deficit hyperactivity disorder (ADHD) include:

a. significant evidence that cognitive behavioral therapy does not improve ADHD symptoms in children 7-17 years of age b. child or parent training improved academic performance c. omega-3/6 supplements made a significant difference in ADHD symptoms d. insufficient evidence on the effectiveness of imaging in diagnosing ADHD in children

2. The Diagnostic and Statistical Manual of Mental Disorders (DSM-5) requires which of the following for a child or adolescent to be diagnosed with ADHD:

a. 2 out of 9 inattentive symptoms b. 4 out of 9 hyperactivity symptoms c. Symptoms present for at least 6 months d. Symptoms present before the age of 8

3. This Comparative Effectiveness Review, comparing strategies to diagnose, treat and monitor children with attention deficit hyperactivity disorder (ADHD) included:

a. 10 articles representing 7 studies b. 103 articles representing 90 studies c. 90 articles representing 70 studies d. 50 articles representing 42 studies

4. The strength of evidence (SOE) grade when comparing pharmacological and placebo/usual care treatments in this review was insufficient because of:

a. imprecise findings b. precise findings c. moderately precise findings d. none of the above

5. Regarding neurofeedback as a treatment for ADHD this review found:

a. significant adverse effects from neurofeedback b. inconsistent findings caused insufficient SOE grades c. all the above d. none of the above

6. The review comparing herbal interventions or dietary strategies to diagnose, treat and monitor children with attention deficit hyperactivity disorder (ADHD) included:

a. 10 good quality and 2 fair quality studies b. 3 good quality and 3 fair quality studies c. A total of 486 patients d. B and C

7. In this review comparing strategies to diagnose, treat and monitor children with attention deficit hyperactivity disorder (ADHD) it was found that methylphenidate had slightly higher gastrointestinal effects than atomoxetine.

a. True b. False

8. Risk factors associated with ADHD include:

a. prenatal factors b. perinatal factors c. early postnatal factor d. all the above

9. The K-SADS (Kiddie SAFS) is a:

a. parent interview b. semi-structured diagnostic interview with parent and child c. structured diagnostic interview with parent and/or child d. teacher questionnaire

10. When accessing the SOE for executive function the CANTAB performed better than the ATTEX and CHEXI.

a. True b. False

11. In this review sufficient SOE grades were found for all outcomes when assessing pharmacological versus nonpharmacologic treatments.

a. True b. False

12. In this review the Attention and Executive Function Rating Inventory performed _______________ the Cambridge Neuropsychological Test Automated Battery for the diagnosis of ADHD for ages 7-17

a. better than b. worse than c. equally compared to

13. Adverse effects from pharmacological treatment for ADHD can include:

a. weight increase b. lowered blood pressure c. cardiac arrhythmias d. decreased heart rate

14. In this review, when comparing different ADHD medications including atomoxetine and methphenidate the most commonly reported adverse effects were:

a. somnolence b. mild gastrointestinal problems c. both A and B d. none of the above.

15. The AHRQs Methods guide for assessing Strength of Evidence (SOE) requires assessment of the following:

a. consistency b. study Limitations c. directness d. all the above e. none of the above

16. In this review, when comparing pharmacologic therapies, small numbers of studies with variable quality caused insufficient SOE grades for all outcomes except GI symptoms.

a. True b. False

17. Regarding cognitive training studies included in the 2018 review of the treatment of ADHD:

a. adverse effects were reported in all the included studies. b. large numbers of studies with precise findings caused sufficient SOE grades for all outcomes. c. both the above d. none of the above

18. The 2011 AHRQ systematic review found that adding psychosocial /behavioral interventions to psychostimulants _________________ psychosocial/behavioral interventions alone for children with ADHD and oppositional defiant disorder.

a. True b. False

19. The DBDRS (Disruptive Behavior Disorder Rating Scale) is a:

a. parent interview b. semi-structured diagnostic interview with parent and child c. structured diagnostic interview with parent and/or child d. parent questionnaire and Teacher questionnaire

20. The 2018 meta-analysis of treatment for ADHD looked at nutritional therapy and found:

a. significant impact of omega- 3/6 supplements on parent rating scales of ADHD symptoms b. significant impact of omega- 3/6 supplements on teacher rating scales of ADHD symptoms c. no impact of omega- 3/6 supplements on teacher rating scales of ADHD symptoms d. no impact of omega- 3/6 supplements on parent rating scales of ADHD symptoms e. C and D

21. Which of the following were found in this review?

a. Cognitive behavioral therapy improved ADHD symptoms b. Child or parent training did not improve ADHD symptoms c. Child or parent training made a significant difference in academic performance d. Omega 3/6 fatty acid supplementation made a difference in academic performance

22. The Connor CPT (Continuous Performance Test) assesses:

a. attention b. impulsivity c. vigilance d. all of the Above

23. Questions remain about the comparative effectiveness of pharmacotherapy alone or in combination with behavioral therapy due to:

a. the complex nature of ADHD b. specific factors related to the child c. all the above d. none of the above

24. In this review, studies assessing child or parent training, or behavioral interventions found that ADHD symptoms were significantly improved with:

a. child or parent training b. sleep hygiene c. behavioral interventions d. all the above

Course Description

Improve your knowledge on the Diagnosis and Treatment of ADHD in Children and Adolescents with this course. Attention Deficit Hyperactivity Disorder (ADHD) is a neurodevelopmental disorder characterized by excessive amounts of inattention, hyperactivity, and impulsivity that are pervasive and impairing in multiple contexts. ADHD symptoms arise from executive dysfunction and emotional dysregulation is often considered a core symptom (Brown, 2008). This systematic review updates and extends two previous Agency for Healthcare Research and Quality (AHQR) systematic evidence reviews. It focuses on the comparative effectiveness of methods to establish the diagnosis of ADHD, updates the comparative effectiveness of pharmacologic and nonpharmacologic treatments, and evaluates different monitoring strategies in the primary care setting. The data sources consist of numerous relevant English-language studies published between 2011 and 2016 in PubMed, Embase, PsycINFO and the Cochrane Database of Systematic Reviews.

Learning Objectives

describe the process used to evaluate the Strength of Evidence (SOE) for studies included in the 2018 Comparative Effectiveness Review Number 203 comparing strategies to diagnose, treat and monitor children with attention deficit hyperactivity disorder (ADHD).
list a variety of pharmacological and non-pharmacological treatments used for children with ADHD and describe the findings for studies related to these treatments.
identify key messages of the 2018 Comparative Effectiveness Review Number 203 comparing strategies to diagnose, treat and monitor children with attention deficit hyperactivity disorder (ADHD).

Source

Click Tab on Left Prepared by the following investigators at Duke Evidence-based Practice Center Durham, NC:

Alex R. Kemper, M.D., M.P.H, M.S.
Gary R. Maslow, M.D., M.P.H.
Sherika Hill, M.H.A., Ph.D.
Behrouz Namdari, M.D.
Nancy M. Allen LaPointe, Pharm.D., M.H.S.
Adam P. Goode, D.P.T., Ph.D.
Remy R. Coeytaux, M.D., Ph.D.
Deanna Befus, B.A., B.S.N.
Andrzej S. Kosinski, Ph.D.
Samantha E. Bowen, Ph.D.
Amanda J. McBroom, Ph.D.
Kathryn R. Lallinger, M.S.L.S.
Gillian D. Sanders, Ph.D.

Psychologist